4//SEC Filing
Rakhit Amit 4
Accession 0001209191-21-046995
CIK 0001636651other
Filed
Jul 15, 8:00 PM ET
Accepted
Jul 16, 6:21 PM ET
Size
9.1 KB
Accession
0001209191-21-046995
Insider Transaction Report
Form 4
Rakhit Amit
CMO and PMO
Transactions
- Exercise/Conversion
Stock Option (Right to Buy)
2021-07-14+34,017→ 90,983 totalExercise: $1.89Exp: 2029-02-23→ Common Stock (34,017 underlying) - Sale
Common Stock
2021-07-14$3.71/sh−34,017$126,203→ 726,823 total - Exercise/Conversion
Common Stock
2021-07-14$1.89/sh+34,017$64,292→ 760,840 total
Footnotes (2)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $3.70 to $3.745, inclusive. The reporting person undertakes to provide to Ovid Therapeutics Inc, any security holder of Ovid Therapeutics Inc, or staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this Footnote 1 to this Form 4
- [F2]25% of the Stock Options vested and become exercisable on February 24, 2020 and the remaining shares will vest in 36 equal monthly installments thereafter subject to the Reporting Person's continued services through such date.
Documents
Issuer
Ovid Therapeutics Inc.
CIK 0001636651
Entity typeother
Related Parties
1- filerCIK 0001704636
Filing Metadata
- Form type
- 4
- Filed
- Jul 15, 8:00 PM ET
- Accepted
- Jul 16, 6:21 PM ET
- Size
- 9.1 KB